This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3297) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1514) Anxiety and Stress Disorders (1053) Depression and Mood Disorders; Suicide Prevention (1363) Emotional, Social, Psychological Support for Cancer (194)

Published on in Vol 21, No 10 (2019): October

Development of the Therapeutic Alliance and its Association With Internet-Based Mindfulness-Based Cognitive Therapy for Distressed Cancer Patients: Secondary Analysis of a Multicenter Randomized Controlled Trial

Development of the Therapeutic Alliance and its Association With Internet-Based Mindfulness-Based Cognitive Therapy for Distressed Cancer Patients: Secondary Analysis of a Multicenter Randomized Controlled Trial

Development of the Therapeutic Alliance and its Association With Internet-Based Mindfulness-Based Cognitive Therapy for Distressed Cancer Patients: Secondary Analysis of a Multicenter Randomized Controlled Trial

Authors of this article:

Else Bisseling1 Author Orcid Image ;   Linda Cillessen1 Author Orcid Image ;   Philip Spinhoven2, 3 Author Orcid Image ;   Melanie Schellekens4 Author Orcid Image ;   Félix Compen1 Author Orcid Image ;   Marije van der Lee4 Author Orcid Image ;   Anne Speckens1 Author Orcid Image
Article Authors Cited by (20) Tweetations (21) Metrics

    Original Paper

    1Radboudumc for Mindfulness, Department of Psychiatry, Radboud University Medical Center, Nijmegen, Netherlands

    2Institute of Psychology, Leiden University, Leiden, Netherlands

    3Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands

    4Helen Dowling Institute, Centre for Psycho-Oncology, Scientific Research Department, Bilthoven, Netherlands

    *all authors contributed equally

    Corresponding Author:

    Else Bisseling, MD

    Radboudumc for Mindfulness

    Department of Psychiatry

    Radboud University Medical Center

    966/CvM, Postbus 9101

    Nijmegen, 6500HB

    Netherlands

    Phone: 31 243615445

    Email: else.bisseling@radboudumc.nl


    Background: Mindfulness-based cognitive therapy (MBCT) is an evidence-based group-based psychological treatment in oncology, resulting in reduction of depressive and anxiety symptoms. Internet-based MBCT (eMBCT) has been found to be an effective alternative for MBCT. The therapeutic alliance (the bond between therapist and patient,) is known to have a significant impact on psychological treatment outcomes, including MBCT. A primary concern in the practice of eMBCT is whether a good therapeutic alliance can develop. Although evidence for the beneficial effect of therapist assistance on treatment outcome in internet-based interventions (IBIs) is accumulating, it is still unclear whether the therapeutic alliance is related to outcome in IBIs.

    Objective: This study aimed to (1) explore whether early therapeutic alliance predicts treatment dropout in MBCT or eMBCT, (2) compare the development of the therapeutic alliance during eMBCT and MBCT, and (3) examine whether early therapeutic alliance is a predictor of the reduction of psychological distress and the increase of mental well-being at posttreatment in both conditions.

    Methods: This study was part of a multicenter randomized controlled trial (n=245) on the effectiveness of MBCT or eMBCT for distressed cancer patients. The therapeutic alliance was measured at the start of week 2 (ie, early therapeutic alliance), week 5, and week 9. Outcome measures were psychological distress, measured with the Hospital Anxiety and Depression Scale, and mental well-being, measured with the Mental Health Continuum-Short Form.

    Results: The strength of early therapeutic alliance did not predict treatment dropout in MBCT or eMBCT (B=−.39; P=.21). Therapeutic alliance increased over time in both conditions (F2,90=16.46; Wilks λ=0.732; P<.001). This increase did not differ between eMBCT and MBCT (F1,91=0.114; P=.74). Therapeutic alliance at week 2 predicted a decrease in psychological distress (B=−.12; t114=−2.656; P=.01) and an increase in mental well-being (B=.23; t113=2.651; P=.01) at posttreatment. The relationship with reduction of psychological distress differed between treatments: a weaker early therapeutic alliance predicted higher psychological distress at posttreatment in MBCT but not in eMBCT (B=.22; t113=2.261; P=.03).

    Conclusions: A therapeutic alliance can develop in both eMBCT and MBCT. Findings revealed that the strength of early alliance did not predict treatment dropout. Furthermore, the level of therapeutic alliance predicted reduced psychological distress and increased mental well-being at posttreatment in both conditions. Interestingly, the strength of therapeutic alliance appeared to be more related to treatment outcome in group-based MBCT than in eMBCT.

    Trial Registration: ClinicalTrials.gov NCT02138513; https://clinicaltrials.gov/ct2/show/NCT02138513

    J Med Internet Res 2019;21(10):e14065

    doi:10.2196/14065

    Keywords

    therapeutic alliance; telemedicine; mindfulness; cancer; patient dropouts 


    Background

    From 2025 onward, 20 million people worldwide will be diagnosed with cancer each year [1]. Approximately one-third of all cancer patients suffer from psychological distress [2], resulting in long-lasting reduced quality of life, decreased compliance with medical care, and prolonged duration of hospital stay [3,4]. Mindfulness-based interventions (MBIs) such as mindfulness-based cognitive therapy (MBCT) [5] are viable psychological treatment options for cancer patients. Mindfulness is defined as “Paying attention; on purpose, in the present moment and non-judgmentally” [6]. MBIs are effective in reducing psychological distress in cancer patients [7,8]. However, as MBIs typically require in-person attendance at a series of classes over several weeks, many cancer patients experience barriers to participate due to illness, side effects of anticancer treatment, fatigue, limited mobility, or transport options [9].

    Internet-based MBCT (eMBCT), overcoming many of these barriers, was found to be as effective as face-to-face (f2f) group-based MBCT in reducing psychological distress and in improving positive mental health and quality of life in a multicenter randomized controlled trial (RCT) in cancer patients [10]. Although treatment dropout was higher in eMBCT than in MBCT, this did not influence treatment efficacy. In the long term, the reduction of psychological distress was significantly higher in eMBCT than in MBCT [11].

    The effectiveness of a psychological intervention depends on therapist skills and the strength of the established therapeutic relationship or the therapeutic alliance [12,13]. Therapeutic alliance is defined as the collaborative and affective bond between the therapist and the patient [14,15]. A good alliance means that the patient and therapist are working well toward the goals of the therapy [16]. The quality of the therapeutic alliance can be attributed to the change in outcome of psychological interventions [17,18]. Alliance measures can assess this working relationship [16]. The therapeutic alliance is often assessed with the Working Alliance Inventory (WAI) [19], measuring the degree of mutual trust between the client and therapist, their agreement on treatment goals, and their agreement on how to reach these goals. Alliance is commonly measured early, middle, and late in therapy. Early alliance strength does seem to be associated with outcome [16]. The significant impact of therapeutic alliance on f2f psychotherapy outcomes has been demonstrated in several meta-analyses [18,20]. It was recently found that therapeutic alliance also predicts the outcome of MBCT in cancer patients [21].

    A systematic review of the therapeutic alliance in internet-based interventions (IBIs) indicated the development of therapeutic alliance to be equivalent to its development in f2f therapy [22]. In addition, Reynolds found that clients (n=30) and therapists (n=30) rated their session impact and alliances in Web-based text psychotherapy as strong as previously found in f2f psychotherapy [23]. With regard to the association between therapeutic alliance and outcome, findings are mixed. Earlier research found an association between therapeutic alliance and outcome in internet-based cognitive behavioral therapy (CBT) for depression and symptoms of posttraumatic stress [24,25] and in blended CBT for depression [26]. In a sample of cancer survivors (n=46), it was found that a strong therapeutic alliance predicted depressive symptom reduction in telephone-assisted CBT [27]. However, in other studies, no significant relationship between treatment outcome and the therapeutic alliance was found [28,29]. As far as we know, no studies have been conducted on the association of therapeutic alliance and outcome in eMBCT, although online mindfulness interventions are increasingly used [30]. To date, findings in internet-based formats are uncertain, and the relationship between therapeutic alliance and outcome of internet-based psychological interventions remains understudied [31]. The main aim of this study was to contribute to the ongoing debate in psychotherapy research on the relative importance of the therapeutic relationship on treatment outcome in (internet-based) psychological interventions. Gaining knowledge about whether therapeutic aspects, such as therapeutic alliance, influence outcome in eMBCT might improve therapeutic strategies and adequate implementation strategies.

    Objectives

    The objectives of this study were to (1) explore whether early therapeutic alliance predicts treatment dropout in MBCT or eMBCT, (2) compare the development of the therapeutic alliance during eMBCT and MBCT, and (3) examine whether early therapeutic alliance is a predictor of the reduction of psychological distress and the increase of mental well-being at posttreatment in both conditions.


    Design

    This study was part of a large multicenter RCT (n=245) on the effectiveness of MBCT and eMBCT versus treatment as usual (TAU) for distressed cancer patients. The study was registered on Clinicaltrials.gov (NCT02138513) shortly after the start of recruitment, reported following CONSORT guidelines [32], and a protocol paper was published in advance [10,33]. Participants were randomized to MBCT, eMBCT, or TAU. After 3 months, patients in TAU were randomly allocated to either MBCT or eMBCT.

    This study involved data from all patients randomized to MBCT or eMBCT, including those patients who were randomized to MBCT or eMBCT after they had completed the 3-month TAU period. The local ethics committee approved this study (CMO Arnhem Nijmegen 2013/542). All participants provided written informed consent before study enrolment.

    Study Population and Procedure

    Patients were recruited in specialized mental health care institutes for psycho-oncology via social media, patient associations, and advertorials in local newspapers in the Netherlands. Patients who were interested in participation could enroll themselves at the study website for a screening assessment with the Hospital Anxiety and Depression Scale (HADS). Patients with a score of 11 or greater on the HADS were contacted by telephone by one of the researchers to assess eligibility. Inclusion criteria were as follows: (1) having any cancer diagnosis, (2) experiencing at least mild psychological distress, (3) computer literacy and access to the internet, (4) good command of the Dutch language, and (5) willingness to participate in either online or f2f group–based MBCT. Exclusion criteria were as follows: (1) severe psychiatric morbidity such as suicidal ideation or psychosis, (2) change in psychotropic medication within 3 months of baseline, and (3) current or previous participation in MBCT or mindfulness-based stress reduction. Before randomization, patients completed the baseline assessment.

    Intervention and Therapists

    MBIs, such as MBCT [5], are innovative and effective psychological treatment options and have increasingly been applied in somatic health care, including oncology. Mindfulness is defined as intentionally paying attention to present-moment experiences in an accepting and nonjudgmental way [34]. They were originally developed for patients with chronic somatic conditions to help them cope more effectively with their condition, by increasing the capacity to focus on present-moment experiences, even in the presence of internal discomfort, and furthermore to prevent relapse in patients with recurrent major depressive disorders [5]. More recently, it has been applied in other conditions [35]. A 2012 meta-analysis of 9 RCTs (n=955) of MBIs in cancer patients found significant improvements in depressive and anxiety symptoms [7]. Since then, a number of RCTs have replicated the reduction of distress following MBIs [36-40].

    Group-Based Mindfulness-Based Cognitive Therapy

    Patients randomized to group-based MBCT received the intervention according to the MBCT protocol of Segal et al [5]. The MBCT protocol was tailored to cancer patients by including cancer-related psychoeducation and adapted movement exercises. The group-based MBCT consisted of 8 weekly 2.5-hour group sessions, one 6-hour silent day, and daily home practice assignments guided by audio files. The sessions consisted of mindfulness practices, sharing experiences, and didactic teachings. Each participant received a folder with information on each session and a CD containing the audio files. The group-based MBCT was provided at the Radboud University Medical Center in Nijmegen, the Jeroen Bosch Hospital in 's-Hertogenbosch, and 4 mental health institutes specialized in psycho-oncology (Helen Dowling Institute in Bilthoven, Ingeborg Douwes Centrum in Amsterdam, de Vruchtenburg in Rotterdam/Leiden, and Het Behouden Huys in Haren).

    Internet-Based Mindfulness-Based Cognitive Therapy

    The eMBCT followed exactly the same protocol as the group-based MBCT. The eMBCT was mainly text based and included asynchronous written interaction with a therapist over email, similar to the study by Bruggeman-Everts et al [41]. Patients were given access to a website divided into a workspace containing 9 sessions (8 weeks+1 full-day silent retreat) and a secured inbox. The silent day consists of a 6-hour program of practicing mindfulness in silence, with various exercises, and a lunch and tea breaks in silence. The therapist initiated the eMBCT by sending a welcome message to the patient, personalized with a photo or brief description of oneself as introduction. When patients logged in, they were presented with the overview of all information and assignments due for that week. Each session contained an introductory text; daily formal (eg, sitting meditation) and informal exercises (eg, awareness of everyday activities); and other home practice, with guided audio files and accompanying diaries. They were shown (fictional) patients’ descriptions to emphasize common experiences and clarify the use of the logfiles. The therapist provided written feedback on the completed logfiles via the secured inbox on a prearranged day of the week. Patients were given written instructions after week 5 to prepare for their silent day at home. In the week of the silent day, patients were provided with a program similar to the MBCT silent day. Having completed 4 or more sessions of MBCT was defined as a minimum adequate dose in both interventions [42].

    Therapists

    A total of 14 therapists participated: 7 taught both interventions, 2 taught only MBCT, and 5 taught only eMBCT. All therapists fulfilled the advanced criteria of the Association of Mindfulness-Based Teachers in the Netherlands and Flanders, which are in concordance with the UK Mindfulness-Based Teacher Trainer Network Good Practice Guidelines [43]. All therapists had previous experience in working with oncology patients and received a 2-day training workshop in the MBCT study protocol at the start of the study. Moreover, 2 additional day-long supervision meetings were organized during the intervention phase of 1 year and 6 months. Therapists without previous eMBCT experience were provided with guidelines and were supervised by more experienced eMBCT therapists.

    Measures

    Therapeutic Alliance

    Therapeutic alliance was measured with a translated and shortened form of the WAI [19], which was administered at the start of week 2, week 5, and week 9. The WAI consists of 3 subscales assessing (1) how closely client and therapist agree on and are mutually engaged in the goals of treatment; (2) how closely client and therapist agree on how to reach the treatment goals; and (3) the degree of mutual trust, acceptance, and confidence between the client and therapist. Items were scored on a 5-point scale ranging from rarely (0) to always (5) [44,45]. The 12-item inventory was validated in a Dutch-speaking sample, showing an internal consistency of greater than 0.80 for all separate subscales and 0.87 for the total scale [46]. The scale was used before in oncology patients following eMBCT [47]. Internal consistency of the total scale of the version used in this study was high (Cronbach alpha=.93).

    Psychological Distress

    Psychological distress was measured with the 14-item HADS developed to measure depression and anxiety in general medical populations [32]. Items were scored on a 4-point scale ranging from rarely (0) to almost always (4). It has been validated in medical populations, including cancer patients [48], and has adequate psychometric properties to detect distress and to screen for psychiatric disorders in cancer patients [49,50]. Internal consistency of the total scale in the present sample was high (Cronbach alpha=.87). Patients completed the HADS before and after the intervention.

    Mental Well-Being

    Mental well-being was measured by the Mental Health Continuum-Short Form (MHC-SF) [51], which comprises 14 items, representing various feelings of well-being in the past month rated on a 6-point Likert scale from never (0), once or twice a week (1), about once a week (2), 2 or 3 times a week (3), almost every day (4), and every day (5). The MHC-SF contains 3 subscales: emotional, psychological, and social well-being. The short form of the MHC-SF has shown excellent internal consistency (>0.80). The test-retest reliability of the MHC-SF over 3 successive 3-month periods was 0.68, and the 9-month test-retest in a Dutch sample was 0.65 [52]. Internal consistency of the total scale in the sample used in this study was high (Cronbach alpha=.97). Patients completed the MHC-SF before and after the intervention.

    Statistical Analyses

    All analyses were conducted in SPSS version 25.0 (IBM Corp, 2017). Differences between conditions and between completers and noncompleters (<4 sessions attended) in demographic and clinical variables were tested with chi-square tests and t tests. To test whether strength of alliance predicted dropout of eMBCT and MBCT, binary logistic regression analyses were used.

    For further analyses, we only included patients who completed MBCT or eMBCT (n=163). To test the development of the therapeutic alliance during eMBCT and MBCT, repeated-measures analyses of variance were used. To examine whether therapeutic alliance predicted outcome and whether this was different in the 2 conditions, separate hierarchical linear regression models were conducted. The dependent variable was posttreatment psychological distress (HADS) or mental well-being (MHC-SF). In the first step, independent variables were the baseline level of psychological distress or mental well-being and condition (MBCT/eMBCT). In the second step, therapeutic alliance at week 2 was included as predictor. In the third step, the interaction between condition and therapeutic alliance was added to test moderation.


    Participants

    Of the cancer patients participating in the RCT (n=245), 125 were randomized to eMBCT and 120 were randomized to MBCT. Of all patients (n=125) randomized to eMBCT, 22 (19.2%) declined participation after randomization. Of all patients (n=120) randomized to MBCT, 25 (20.8%) declined participation after randomization (see Figure 1). Participants were mostly female, middle aged, and highly educated. Most patients were diagnosed with breast cancer and were treated with a curative intent (see Table 1).

    ‎
    Figure 1. Flowchart of the sample used in the present study. eMBCT: internet-based mindfulness-based cognitive therapy; MBCT: mindfulness-based cognitive therapy.
    View this figure
    Table 1. Sample characteristics per intervention (mindfulness-based cognitive therapy/internet-based mindfulness-based cognitive therapy).
    CharacteristicsMindfulness-based cognitive therapya (n=120)Internet-based mindfulness-based cognitive therapya (n=125)Chi-square (df)t test (df)P value
    Sociodemographics

    		Gender (female), n (%)101 (84.2)109 (87.2)0.5 (1,244)—b.50

    		Relation (yes), n (%)102 (85.0)100 (80.0)1.6 (1,244)—.40

    		Children, n (%)79 (65.8)90 (72.0)1.1 (1,244)—.30

    		Education level, n (%)

    		 Low/middle35 (29.2)44 (35.4)1.02 (1,244)—.31

    		 High85 (70.8)81 (64.8)1.02 (1,244)—.31

    		Age (years), mean (SD)51.5 (11.1)51.8 (10.2)—−0.18 (243).86
    Clinical

    		Cancer diagnosis,n (%)


    		Breast75 (62.5)76 (60.8)0.08 (1,244)—.78


    		Other45 (37.5)49 (39.2)0.08 (1,244)—.78

    		Treatment intent, n (%)


    		Curative104 (86.7)102 (81.6)1.17 (1,244)—.28


    		Palliative16 (13.3)23 (18.4)1.17 (1,244)—.28

    		Current anticancer treatment (yes), n (%)56 (46.7)60 (48.0)0.44 (1,244)—.83

    		Psychiatric diagnosis (yes), n (%)44 (36.0)45 (36.7)0.012 (1,244)—.91

    		Time since diagnosis, mean (SD)3.5 (5.0)3.4 (4.4) 0.21 (243).84

    		Psychological distress, Hospital Anxiety and Depression Scale, mean (SD)18.2 (6.7)16.9 (6.9)1.49 (1,244)—.14

    		Mental well-being, Mental Health Continuum-Short Form, mean (SD)35.0 (12.8)37.4 (13.6)−1.46 (1,244)—.15

    aBoth categories include the patients that were initially randomized to the treatment as usual group.

    bNot applicable.

    Dropout

    Of the patients who started MBCT or eMBCT (n=198), 35 (17.7%) dropped out of the intervention. Dropout rate in eMBCT (n=24, 12.1%) was significantly higher than that in MBCT (n=11, 5.6%; P=.03). There were no differences in sociodemographics between participants who completed MBCT or eMBCT and those who did not.

    Patients who dropped out after the first sessions did not fill out the WAI questionnaire and, consequently, were not included in the analyses testing whether early therapeutic alliance predicted dropout of eMBCT and MBCT. However, reasons for dropout after session 1 were collected. Main reason was that the intervention was not as expected (n=6, 25.7%). Other reasons for dropout are summarized in Multimedia Appendix 1.

    Analyses testing whether early therapeutic alliance predicted dropout of eMBCT and MBCT revealed that there was no significant difference in early therapeutic alliance between participants who dropped out of the intervention (mean 33.3, SD 7.9) and those who completed MBCT or eMBCT (mean 36.6, SD 9.5; P=.23). Moreover, this effect was not moderated by treatment condition, as there was no significant interaction between condition and the therapeutic alliance at the start of week 2 in association with dropout (B=−.13; P=.08).

    Development of Therapeutic Alliance

    As shown in Figure 2, level of therapeutic alliance increased significantly over time (F2,90=16.46; Wilks ʎ=0.732; P<.001) and did not differ significantly between conditions (P=.74). There was no significant interaction between condition and time (F2,90=1.636; Wilks ʎ=0.965; P=.20), implying that the development of therapeutic alliance did not differ between eMBCT and MBCT either.

    ‎
    Figure 2. Mean level of therapeutic alliance throughout mindfulness-based cognitive therapy and internet-based mindfulness-based cognitive therapy. eMBCT: internet-based mindfulness-based cognitive therapy; MBCT: mindfulness-based cognitive therapy.
    View this figure

    Association of Therapeutic Alliance With Treatment Outcome

    As you can see in Tables 2 and 3, early therapeutic alliance predicted both reduction of psychological distress (B=−.12; t114=−2.656; P=.01) and increase of mental well-being (B=.23; t113=2.651; P=.01) at posttreatment. Adding the interaction term between early therapeutic alliance and condition resulted in a significant increase in explained variance (∆R2=0.031; F1,114=6.622; P=.01). The relationship between early therapeutic alliance and psychological distress at posttreatment was moderated by condition (B=.22; t113=2.245; P=.03).

    Examination of the interaction plot showed that participants of the group-based MBCT with a weaker early therapeutic alliance showed a significant higher level of psychological distress at posttreatment than those of eMBCT (P=.004; see also Multimedia Appendix 2).

    Table 2. Relationship between therapeutic alliance and psychological distress: regression analyses. Italicized values indicate significance.
    VariablesRegression analyses of psychological distressPredictor

    		F value (df)P valueAdjusted R2Betat testP value
    Psychological distress baseline42.72 (2,115)<.0010.416.588.69 (113)<.001
    Condition42.72 (2,115)<.0010.416−2.3−2.36 (113).01
    Therapeutic alliance week 2a32.08 (3,114)<.0010.443−.12−2.57 (113).01
    Therapeutic alliance week 2×conditiona26.17 (4,113)<.0010.463.222.245 (113).03

    aCorrected for baseline psychological distress and the condition, and the predictor×intervention interaction and psychological distress at posttreatment with separate hierarchical linear regressions (n=163).

    Table 3. Relationship between therapeutic alliance and mental well-being: regression analyses. Italicized values indicate significance.
    VariablesRegression analyses of mental well-beingPredictor

    		F value (df)P valueAdjusted R2Betat testP value
    Mental well-being baseline65.26 (2,115)<.0010.523.7610.84 (113)<.001
    Condition65.26 (2,115)<.0010.5231.91.16 (113).24
    Therapeutic alliance week 2a48.15 (3,114)<.0010.547.242.66 (113).01
    Therapeutic alliance week 2×conditiona36.07 (4,113)<.0010.545−.12−.697 (113).49

    aCorrected for baseline mental well-being and the condition, and the predictor×intervention interaction and mental well-being at posttreatment with separate hierarchical linear regressions (n=163).


    Principal Findings

    The aims of this study were to (1) explore whether the strength of early therapeutic alliance predicts treatment dropout in MBCT or eMBCT, (2) compare the development of the therapeutic alliance during eMBCT and MBCT, and (3) examine whether early therapeutic alliance is a predictor of the reduction of psychological distress and the increase of mental well-being at posttreatment in both conditions. Results showed that early alliance did not predict dropout and that the development of the therapeutic alliance did not differ between eMBCT and MBCT. In addition, early therapeutic alliance predicted the reduction of psychological distress and improvement of mental well-being at posttreatment. Moreover, we found that the association between a weaker therapeutic alliance and smaller reduction of psychological distress was stronger in group-based MBCT than in eMBCT.

    In our sample, dropout rates in eMBCT were somewhat higher than those in MBCT. This is in line with previous research findings that dropout rates in eMBCT are relatively high [10,53]. We could not confirm previous findings that a strong early alliance prevents patients from dropping out of psychological treatment [54]. In this respect, we would like to stress that our findings should be interpreted with caution. We were unable to include data from patients who dropped out after the first session because early therapeutic alliance was measured at the start of the second session. The main reason for dropping out after the first session was “other expectations.” This finding stresses the importance of clearly explaining the treatment rationale and developing a shared understanding with patients at the start of MBCT or eMBCT. In our study, the therapist initiated the contact in eMBCT by sending a welcome message to the patient. As it was previously found in a qualitative study that in eMBCT asynchronicity of therapist contact/feedback is experienced by some patients as uncomfortable [9], adding an (f2f) appointment with the therapist at the start of eMBCT and synchronous therapist assistance in the early treatment phase might be useful to prevent dropout. Moreover, it was previously found that therapists seem concerned with the level of continuity of the training. Missing out on nonverbal information of patients made them unable to spot withdrawal at an early stage [9]. Alliance building may enhance engagement to treatment. So far, quantitative studies concerning the association of therapeutic alliance and adherence to IBIs are missing. Knowledge about alliance and adherence can be important to define the optimal level of therapist support in IBIs [31].

    Regarding the association of therapeutic alliance and outcome, our findings are in line with previous (meta-analytic) research findings, showing that the therapeutic alliance is associated with outcome in f2f psychotherapy [18,20], including MBCT [21] and IBIs [24,25]. An explanation for the finding that the strength of the early alliance affects the outcome more in MBCT than in eMBCT could be that in a group-based setting, patients with a weak therapeutic alliance might conceal themselves in the group and might put in less effort to share experiences or practice. This might explain why psychological distress levels of those patients remained high compared with patients who experienced a strong therapeutic alliance. As a consequence, particularly in group-based settings, mindfulness therapists should be aware of their way of bonding with patients. Although we did not investigate this in our study, it has been previously found that for patients who have difficulties in building a relationship with others, which might be reflected in a weak therapeutic alliance, therapists who model effective ways of forming a strong alliance can process the formation of a strong (repaired) alliance [55,56], which in turn may lead to better outcome. Another explanation for this finding could be that in individual eMBCT, one’s self-efficacy and intrinsic motivation are also important for treatment outcome than the experienced therapeutic alliance [11]. This is in line with previous qualitative findings in eMBCT for cancer patients, which revealed that participants stressed the importance of self-discipline and the individual nature as facilitators for eMBCT [9] suggesting that experienced motivation and discipline is also related to outcome.

    Strengths and Limitations

    A major strength of this study was that we directly compared the development of therapeutic alliance between patients participating in eMBCT and MBCT. Except for the delivery format, both interventions were similar in content. Moreover, we investigated the relationship between therapeutic alliance and treatment outcome both in terms of symptom reduction and mental well-being. Some limitations, however, need to be mentioned. At first, this study was conducted in a self-selected group of distressed cancer patients. Although this is in line with patients seeking help in clinical practice, this might limit the extent to which the findings of this study generalize to the broader population of cancer patients [57,58]. Second, an inclusion criterium was that participants would agree with randomization to an f2f or online intervention. Our inclusion criterium might have prevented patients that were not interested in online interventions from participating. This might limit the extent to which the present findings generalize to the broader population of cancer patients.

    Research Implications

    Further research should investigate the relation between therapeutic alliance and dropout more thoroughly, for instance, by measuring therapeutic alliance after each session. It would also be interesting to focus on examining what therapeutic techniques might be suitable to improve the development of a strong therapeutic alliance, both in eMBCT and MBCT. Further research in eMBCT could examine how therapeutic alliance can develop in different MBCT or eMBCT formats and how this influences treatment outcome. Treatment formats could vary from blended care to intensive synchronous individual therapist-assisted eMBCT to stand-alone eMBCT with computerized feedback.

    Clinical Implications

    As dropout rates were somewhat higher in eMBCT, efforts should be taken to prevent dropout. It is of interest to shed more light on how to encourage patients to adhere to the treatment. Building a good therapeutic alliance is of clinical importance in MBCT or eMBCT. By measuring therapeutic alliance as a routine outcome after every session, therapists can be encouraged to really tune in to patient’s needs and adjust their therapy or their therapeutic attitude at an early treatment stage, which may benefit treatment outcome in both MBCT and eMBCT.

    Acknowledgments

    This research was funded by the Dutch national cancer foundation (KWF Kankerbestrijding; Grant no. 2012.WO14.C153). The authors would like to thank all patients and therapists who participated in this study and Heidi Willemse, Eva Witteveen, and David Huijts for their help in collecting data.

    Conflicts of Interest

    None declared.

    ‎
    Multimedia Appendix 1

    Dropout rates and reasons for dropout per condition.

    PDF File (Adobe PDF File), 93 KB
    ‎
    Multimedia Appendix 2

    The association of early therapeutic alliance and outcome per condition.

    PNG File , 103 KB
    1. Bray F. Transitions in human development and implications for cancer prevention and control. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. Washington, DC: World Bank Publications; 2014:54-68.
    2. Carlson L, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004 Jun 14;90(12):2297-2304 [FREE Full text] [CrossRef] [Medline]
    3. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011 Feb;12(2):160-174. [CrossRef] [Medline]
    4. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 2013 Jul;14(8):721-732. [CrossRef]
    5. Segal ZV, Williams JM, Teasdale JD. Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse. New York: Guildford Press; 2013.
    6. Kabat-Zinn J. Full Catastrophe Living: How to Cope With Stress, Pain and Illness Using Mindfulness Meditation. London: Piatkus Books; 2013.
    7. Piet J, Würtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol 2012 Dec;80(6):1007-1020. [CrossRef] [Medline]
    8. Zainal NZ, Booth S, Huppert FA. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psychooncology 2013 Jul;22(7):1457-1465. [CrossRef] [Medline]
    9. Compen FR, Bisseling EM, Schellekens MP, Jansen ET, van der Lee ML, Speckens AE. Mindfulness-based cognitive therapy for cancer patients delivered via internet: qualitative study of patient and therapist barriers and facilitators. J Med Internet Res 2017 Dec 18;19(12):e407 [FREE Full text] [CrossRef] [Medline]
    10. Compen F, Bisseling EM, Schellekens MP, Donders R, Carlson L, van der Lee M, et al. Face-to-face and internet-based mindfulness-based cognitive therapy compared with treatment as usual in reducing psychological distress in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 2018 Aug 10;36(23):2413-2421. [CrossRef] [Medline]
    11. Cillessen L, Schellekens MP, van de Ven MO, Donders AR, Compen FR, Bisseling EM, et al. Consolidation and prediction of long-term treatment effect of group and online mindfulness-based cognitive therapy for distressed cancer patients. Acta Oncol 2018 Oct;57(10):1293-1302. [CrossRef] [Medline]
    12. Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J, et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology 2003 Sep;12(6):532-546. [CrossRef] [Medline]
    13. Wise TN, Biondi M, Costantini A. Psycho-Oncology. Washington, DC: American Psychiatric Publishing; 2013.
    14. Bordin ES. Theory and research on the therapeutic working alliance: new directions. In: Horvath AO, Greenberg LS, editors. The Working Alliance: Theory, Research, and Practice. Hoboken, New Jersey, United States: Wiley; 1994:13-37.
    15. Luborsky L. Therapeutic alliances as predictors of psychotherapy outcomes: factors explaining the predictive success. In: Horvath AO, Greenberg LS, editors. The Working Alliance: Theory, Research, and Practice. Hoboken, New Jersey, United States: Wiley; 1994:38-50.
    16. Muran CJ, Barber JP, editors. The Therapeutic Alliance: An Evidence-Based Guide to Practice. New York, United States: The Guilford Press; 2010.
    17. Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: a meta-analysis. J Couns Psychol 1991;38(2):139-149. [CrossRef]
    18. Horvath AO, del Re AC, Flückiger C, Symonds D. Alliance in individual psychotherapy. Psychotherapy (Chic) 2011 Mar;48(1):9-16. [CrossRef] [Medline]
    19. Horvath AO, Greenberg LS. Development and validation of the working alliance inventory. J Couns Psychol 1989 Apr;36(2):223-233. [CrossRef]
    20. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol 2000 Jun;68(3):438-450. [CrossRef] [Medline]
    21. Bisseling EM, Schellekens MP, Spinhoven P, Compen FR, Speckens AE, van der Lee ML. Therapeutic alliance-not therapist competence or group cohesion-contributes to reduction of psychological distress in group-based mindfulness-based cognitive therapy for cancer patients. Clin Psychol Psychother 2019 May;26(3):309-318 [FREE Full text] [CrossRef] [Medline]
    22. Sucala M, Schnur JB, Constantino MJ, Miller SJ, Brackman EH, Montgomery GH. The therapeutic relationship in e-therapy for mental health: a systematic review. J Med Internet Res 2012 Aug 2;14(4):e110 [FREE Full text] [CrossRef] [Medline]
    23. Reynolds Jr DJ, Stiles WB, Bailer AJ, Hughes MR. Impact of exchanges and client-therapist alliance in online-text psychotherapy. Cyberpsychol Behav Soc Netw 2013 May;16(5):370-377 [FREE Full text] [CrossRef] [Medline]
    24. Nordgren LB, Carlbring P, Linna E, Andersson G. Role of the working alliance on treatment outcome in tailored internet-based cognitive behavioural therapy for anxiety disorders: randomized controlled pilot trial. JMIR Res Protoc 2013 Jan 18;2(1):e4 [FREE Full text] [CrossRef] [Medline]
    25. Wagner B, Brand J, Schulz W, Knaevelsrud C. Online working alliance predicts treatment outcome for posttraumatic stress symptoms in Arab war-traumatized patients. Depress Anxiety 2012 Jul;29(7):646-651. [CrossRef] [Medline]
    26. Ly KH, Topooco N, Cederlund H, Wallin A, Bergström J, Molander O, et al. Smartphone-supported versus full behavioural activation for depression: a randomised controlled trial. PLoS One 2015;10(5):e0126559 [FREE Full text] [CrossRef] [Medline]
    27. Applebaum AJ, DuHamel KN, Winkel G, Rini C, Greene PB, Mosher CE, et al. Therapeutic alliance in telephone-administered cognitive-behavioral therapy for hematopoietic stem cell transplant survivors. J Consult Clin Psychol 2012 Oct;80(5):811-816 [FREE Full text] [CrossRef] [Medline]
    28. Knaevelsrud C, Maercker A. Does the quality of the working alliance predict treatment outcome in online psychotherapy for traumatized patients? J Med Internet Res 2006 Dec 19;8(4):e31 [FREE Full text] [CrossRef] [Medline]
    29. Preschl B, Maercker A, Wagner B. The working alliance in a randomized controlled trial comparing online with face-to-face cognitive-behavioral therapy for depression. BMC Psychiatry 2011 Dec 6;11(1):49-57. [CrossRef]
    30. Plaza I, Demarzo MM, Herrera-Mercadal P, García-Campayo J. Mindfulness-based mobile applications: literature review and analysis of current features. JMIR Mhealth Uhealth 2013 Nov 1;1(2):e24 [FREE Full text] [CrossRef] [Medline]
    31. Pihlaja S, Stenberg J, Joutsenniemi K, Mehik H, Ritola V, Joffe G. Therapeutic alliance in guided internet therapy programs for depression and anxiety disorders - a systematic review. Internet Interv 2018 Mar;11:1-10 [FREE Full text] [CrossRef] [Medline]
    32. Schulz KF, Altman DG, Moher D, CONSORT Group. Consort 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010 Mar 24;8:18 [FREE Full text] [CrossRef] [Medline]
    33. Compen F, Bisseling EM, van der Lee ML, Adang EM, Donders AR, Speckens AE. Study protocol of a multicenter randomized controlled trial comparing the effectiveness of group and individual internet-based mindfulness-based cognitive therapy with treatment as usual in reducing psychological distress in cancer patients: the BeMind study. BMC Psychol 2015;3:27 [FREE Full text] [CrossRef] [Medline]
    34. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York, United States: Bantam Publishing; 1990.
    35. Crane R. Mindfulness-Based Cognitive Therapy: Distinctive Features. Abingdon, United Kingdom: Routledge; 2017.
    36. Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, et al. Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol 2013 Sep 1;31(25):3119-3126. [CrossRef] [Medline]
    37. Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 2014 Feb 10;32(5):449-457. [CrossRef] [Medline]
    38. Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, et al. Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: a randomized controlled trial. J Clin Oncol 2016 Aug 20;34(24):2827-2834 [FREE Full text] [CrossRef] [Medline]
    39. Johannsen M, O'Connor M, O'Toole MS, Jensen AB, Højris I, Zachariae R. Efficacy of mindfulness-based cognitive therapy on late post-treatment pain in women treated for primary breast cancer: a randomized controlled trial. J Clin Oncol 2016 Oct 1;34(28):3390-3399. [CrossRef] [Medline]
    40. Schellekens MP, van den Hurk DG, Prins JB, Donders AR, Molema J, Dekhuijzen R, et al. Mindfulness-based stress reduction added to care as usual for lung cancer patients and/or their partners: a multicentre randomized controlled trial. Psychooncology 2017 Dec;26(12):2118-2126. [CrossRef] [Medline]
    41. Bruggeman Everts FZ, van der Lee ML, de Jager ME. Web-based individual mindfulness-based cognitive therapy for cancer-related fatigue — a pilot study. Internet Interv 2015 May;2(2):200-213 [FREE Full text] [CrossRef]
    42. Crane C, Williams JM. Factors associated with attrition from mindfulness-based cognitive therapy in patients with a history of suicidal depression. Mindfulness (N Y) 2010 Mar;1(1):10-20 [FREE Full text] [CrossRef] [Medline]
    43. Crane RS, Kuyken W, Williams JM, Hastings RP, Cooper L, Fennell MJ. Competence in teaching mindfulness-based courses: concepts, development and assessment. Mindfulness (N Y) 2012 Mar;3(1):76-84 [FREE Full text] [CrossRef] [Medline]
    44. Stinckens N, Ulburghs A, Claes L. HAN University of Applied Sciences. 2009. De Werkalliantie Als Sleutelelement in Het Therapiegebeuren: Meting Met Behulp Van De Wav-12, De Nederlandstalige Verkorte Versie Van De Working Alliance Inventory   URL: https:/​/www.​han.nl/​onderzoek/​werkveld/​projecten/​alliantiegericht-werken-v/​werkwijze/​_attachments/​2009_-_stinckens_ea_-_de_werkalliantie_als_sleuteleleement_in_het_therapiegebeuren_1_.​pdf [accessed 2019-08-27]
    45. Hatcher RL, Gillaspy JA. Development and validation of a revised short version of the working alliance inventory. Psychother Res 2006 Jan 1;16(1):12-25. [CrossRef]
    46. Janse P, Boezen-Hilberdink L, van Dijk MK, Verbraak MJ, Hutschemaekers GJ. Measuring feedback from clients. Eur J Psychol Assess 2014 Jan;30(2):86-92. [CrossRef]
    47. Wolvers MD, Bruggeman-Everts FZ, van der Lee ML, van de Schoot R, Vollenbroek-Hutten MM. Effectiveness, mediators, and effect predictors of internet interventions for chronic cancer-related fatigue: the design and an analysis plan of a 3-armed randomized controlled trial. JMIR Res Protoc 2015 Jun 23;4(2):e77 [FREE Full text] [CrossRef] [Medline]
    48. Bjelland I, Dahl A, Haug T, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002 Feb;52(2):69-77. [CrossRef] [Medline]
    49. Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the hospital anxiety and depression scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord 2010 Nov;126(3):335-348. [CrossRef] [Medline]
    50. Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009 Nov 4;101(21):1464-1488 [FREE Full text] [CrossRef] [Medline]
    51. Keyes CL. Mental illness and/or mental health? Investigating axioms of the complete state model of health. J Consult Clin Psychol 2005 Jun;73(3):539-548. [CrossRef] [Medline]
    52. Lamers SM, Westerhof G, Bohlmeijer ET, ten Klooster PM, Keyes CL. Evaluating the psychometric properties of the mental health continuum-short form (MHC-SF). J Clin Psychol 2011 Jan;67(1):99-110. [CrossRef] [Medline]
    53. Bruggeman-Everts FZ, Wolvers MD, van de Schoot R, Vollenbroek-Hutten MM, van der Lee ML. Effectiveness of two web-based interventions for chronic cancer-related fatigue compared to an active control condition: results of the 'fitter na kanker' randomized controlled trial. J Med Internet Res 2017 Oct 19;19(10):e336 [FREE Full text] [CrossRef] [Medline]
    54. Swift JK, Greenberg RP. Premature discontinuation in adult psychotherapy: a meta-analysis. J Consult Clin Psychol 2012 Aug;80(4):547-559. [CrossRef] [Medline]
    55. Tsai M, Kohlenberg RJ, Kanter JW. A functional analytic psychotherapy (FAP) approach to the therapeutic alliance. In: Muran JC, Barber JP, editors. The Therapeutic Alliance: An Evidence-Based Guide to Practice. Washington, DC: The Guilford Press; 2010:172-190.
    56. Zilcha-Mano S, Errázuriz P. Early development of mechanisms of change as a predictor of subsequent change and treatment outcome: the case of working alliance. J Consult Clin Psychol 2017 May;85(5):508-520. [CrossRef] [Medline]
    57. Berger T. The therapeutic alliance in internet interventions: a narrative review and suggestions for future research. Psychother Res 2017 Sep;27(5):511-524. [CrossRef] [Medline]
    58. Berger T, Boettcher J, Caspar F. Internet-based guided self-help for several anxiety disorders: a randomized controlled trial comparing a tailored with a standardized disorder-specific approach. Psychotherapy (Chic) 2014 Jun;51(2):207-219. [CrossRef] [Medline]

    ‎
    CBT: cognitive behavioral therapy
    eMBCT: internet-based mindfulness-based cognitive therapy
    f2f: face-to-face
    HADS: Hospital Anxiety and Depression Scale
    IBI: internet-based intervention
    MBCT: mindfulness-based cognitive therapy
    MBI: mindfulness-based intervention
    RCT: randomized controlled trial
    TAU: treatment as usual
    WAI: Working Alliance Inventory

    Edited by P Bamidis; submitted 19.03.19; peer-reviewed by N Papaxristou, S Reppou; comments to author 25.04.19; revised version received 18.06.19; accepted 03.07.19; published 18.10.19

    Copyright

    ©Else Bisseling, Linda Cillessen, Philip Spinhoven, Melanie Schellekens, Félix Compen, Marije van der Lee, Anne Speckens. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 18.10.2019.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.